Market Overview - The pharmaceutical commercial sector experienced a decline of 0.92% on November 18, with Yao Yigou leading the drop [1] - The Shanghai Composite Index closed at 3939.81, down 0.81%, while the Shenzhen Component Index closed at 13080.49, down 0.92% [1] Stock Performance - Notable gainers included: - Ren Da Medical (603108) with a closing price of 15.97, up 2.90% and a trading volume of 278,200 shares, totaling 442 million yuan [1] - People's Tongtai (600829) with a closing price of 17.72, up 6.49% and a trading volume of 1,148,700 shares, totaling 1.902 billion yuan [1] - Major decliners included: - Yao Yigou (300937) with a closing price of 33.95, down 6.37% and a trading volume of 115,000 shares, totaling 396 million yuan [2] - Luhua Pharmaceutical (002788) with a closing price of 10.29, down 5.86% and a trading volume of 467,300 shares, totaling 489 million yuan [2] Capital Flow - The pharmaceutical commercial sector saw a net outflow of 706 million yuan from institutional investors, while retail investors contributed a net inflow of 705 million yuan [2] - The overall capital flow indicates a mixed sentiment, with institutional investors withdrawing while retail investors remained active [2] Individual Stock Capital Flow - Ren Da Medical (603108) had a net inflow of 49.2 million yuan from institutional investors, while retail investors saw a net outflow of 65.5 million yuan [3] - Yao Yigou (300937) experienced a significant net outflow of 560.4 million yuan from institutional investors [3] - The data reflects varying levels of investor confidence across different stocks within the sector [3]

Group 1 - On November 17, Jianfa Zhixin's stock price dropped by 3.44%, with a trading volume of 481 million yuan [1] - The financing data shows that on the same day, Jianfa Zhixin had a financing purchase amount of 43.37 million yuan and a financing repayment of 49.50 million yuan, resulting in a net financing outflow of 6.13 million yuan [1] - As of November 17, the total balance of margin trading for Jianfa Zhixin was 131 million yuan, accounting for 7.50% of its circulating market value [1] Group 2 - As of September 30, Jianfa Zhixin had 38,000 shareholders, an increase of 151.60% compared to the previous period, while the average circulating shares per person decreased by 60.25% to 1,327 shares [2] - For the period from January to September 2025, Jianfa Zhixin achieved an operating income of 14.861 billion yuan, representing a year-on-year growth of 10.18%, and a net profit attributable to shareholders of 230 million yuan, which is a year-on-year increase of 45.01% [2] Group 3 - Jianfa Zhixin, established on August 30, 2010, is located at 288 Yangshupu Road, Yangpu District, Shanghai, and is primarily engaged in the direct sales and distribution of medical devices, as well as providing centralized operation services for medical consumables to terminal hospitals [1] - The main revenue composition of Jianfa Zhixin includes: vascular intervention (55.61%), surgical instruments (21.46%), in vitro diagnostic reagents (13.05%), medical equipment (6.24%), other medical devices (2.79%), SPD and other services (0.63%), and others (0.23%) [1]

Market Overview - The pharmaceutical commercial sector experienced a decline of 1.62% on November 17, with Luyuan Pharmaceutical leading the drop [1] - The Shanghai Composite Index closed at 3972.03, down 0.46%, while the Shenzhen Component Index closed at 13202.0, down 0.11% [1] Stock Performance - Notable gainers included: - Renmin Tongtai (600829) with a closing price of 16.64, up 9.98% and a trading volume of 768,000 shares, totaling 1.276 billion yuan [1] - Other stocks in the sector showed mixed results, with several companies like Shanghai Pharmaceuticals (601607) and Guoyao Yizhi (000028) experiencing declines of 1.20% and 1.53% respectively [1] Capital Flow - The pharmaceutical commercial sector saw a net outflow of 875 million yuan from institutional investors, while retail investors contributed a net inflow of 674 million yuan [2] - The data indicates that retail investors were more active in the market compared to institutional investors during this period [2] Individual Stock Capital Flow - Key stocks with significant capital flow include: - Shuyuan Pingmin (301017) with a net inflow of 17.85 million yuan from institutional investors, while retail investors had a net outflow of 35.94 million yuan [3] - Nanjing Pharmaceutical (600713) had a net inflow of 17.30 million yuan from institutional investors, but also saw outflows from retail investors [3] - Guoyao Yizhi (000028) and Shanghai Pharmaceuticals (601607) also experienced mixed capital flows, with institutional inflows but retail outflows [3]

建发致新今日下跌3.33%，全天换手率46.67%，成交额8.88亿元，振幅12.44%。龙虎榜数据显示，机构 净卖出4470.18万元，营业部席位合计净买入1853.66万元。 深交所公开信息显示，当日该股因日换手率达46.67%上榜，机构专用席位净卖出4470.18万元。 建发致新11月14日交易公开信息 | 买/ | 会员营业部名称 | 买入金额（万 | 卖出金额（万 | | --- | --- | --- | --- | | 卖 | | 元） | 元） | | 买一 | 机构专用 | 2065.03 | 3554.95 | | 买二 | 机构专用 | 2047.86 | 2567.12 | | 买三 | 中国国际金融股份有限公司上海分公司 | 2037.68 | 1153.39 | | 买四 | 机构专用 | 1850.64 | 3448.17 | | 买五 | 广发证券股份有限公司广州马场路广发证券大厦证券营 业部 | 1309.32 | 339.95 | | 卖一 | 机构专用 | 2065.03 | 3554.95 | | 卖二 | 机构专用 | 1850.64 | 3448.17 | | 卖三 ...

Core Insights - The pharmaceutical commercial sector experienced a rise of 1.05% on November 14, with significant gains led by the stock of Jiyu Pingmin, which surged by 20.03% [1] - The Shanghai Composite Index closed at 3990.49, down 0.97%, while the Shenzhen Component Index closed at 13216.03, down 1.93% [1] Stock Performance - Jiyu Pingmin (301017) closed at 16.66 with a gain of 20.03%, trading volume of 141,800 shares and a transaction value of 227 million [1] - Renmin Tongtai (600829) and Kaikai Industry (600272) also saw notable increases of 10.04% and 10.03%, respectively [1] - The pharmaceutical sector's stocks showed a mixed performance, with some stocks like Jianfa Zhixin (301584) and Runda Medical (603108) declining by 3.33% and 1.59% respectively [2] Capital Flow - The pharmaceutical commercial sector saw a net outflow of 497 million from institutional investors, while retail investors contributed a net inflow of 590 million [2][3] - The main stocks experiencing significant net inflows from retail investors included Jiyu Pingmin and Kaikai Industry, while institutional investors showed a preference for stocks like Kaikai Industry [3]

Market Performance - The ChiNext Index rose by 2.55%, closing at 3201.75 points, with a total trading volume of 528.67 billion yuan, an increase of 35.74 billion yuan compared to the previous trading day [1] - Among the tradable ChiNext stocks, 988 stocks closed higher, with 23 stocks rising over 10%, including Fu Xiang Pharmaceutical, Hai Ke New Energy, and Ao Ya Co., which hit the daily limit [1] - The average turnover rate for the ChiNext today was 4.04%, with 34 stocks having a turnover rate exceeding 20% [1] High Turnover Stocks - In the high turnover stocks, 29 stocks increased in price, with Hai Ke New Energy, Zhi De Mai, and Shang Neng Electric hitting the daily limit [2] - The electric power equipment sector had the most stocks with a turnover rate exceeding 20%, totaling 9 stocks, followed by the basic chemical and pharmaceutical sectors, each with 5 stocks [2] Institutional Activity - Nine high turnover ChiNext stocks appeared on the Dragon and Tiger List, with institutional participation in seven of them [3] - Hai Ke New Energy saw a net institutional buy of 135 million yuan, while Shang Neng Electric had a net buy of 115 million yuan [3] - The top net buying firms included Tai He Technology, Shang Neng Electric, and Zhi De Mai, with net buying amounts of 102 million yuan, 91.43 million yuan, and 55.68 million yuan, respectively [3] Fund Flow - Among the high turnover stocks, 22 stocks experienced net inflows from main funds, with Shang Neng Electric, Zhi De Mai, and Tai He Technology leading in net inflow amounts of 517 million yuan, 268 million yuan, and 191 million yuan, respectively [3] - Conversely, stocks like Ke Xiang Co., Kai Neng Health, and Xiang Yuan New Materials saw significant net outflows, with amounts of 290 million yuan, 193 million yuan, and 123 million yuan, respectively [3]

建发致新今日上涨2.08%，全天换手率51.30%，成交额9.43亿元，振幅7.83%。龙虎榜数据显示，机构净 买入3162.92万元，营业部席位合计净买入59.09万元。 深交所公开信息显示，当日该股因日换手率达51.30%上榜，机构专用席位净买入3162.92万元。 建发致新11月13日交易公开信息 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交2.76亿元，其中，买入成交额为1.54亿 元，卖出成交额为1.22亿元，合计净买入3222.01万元。 | 买/卖 | 会员营业部名称 | 买入金额（万元） | 卖出金额（万元） | | --- | --- | --- | --- | | 买一 | 机构专用 | 4321.35 | 2855.45 | | 买二 | 机构专用 | 4028.62 | 3043.07 | | 买三 | 机构专用 | 3336.95 | 2481.78 | | 买四 | 机构专用 | 1829.11 | 1972.82 | | 买五 | 中国国际金融股份有限公司上海分公司 | 1682.67 | 660.44 | | 卖一 | 机构专用 | 4028.62 | 3043.0 ...

Market Overview - As of November 13, the Shanghai Composite Index closed at 4029.50 points, up by 29.36 points, representing a 0.73% increase [1] - The Shenzhen Component Index closed at 13476.52 points, up by 235.91 points, with a 1.78% increase [1] - The ChiNext Index closed at 3201.75 points, up by 79.73 points, reflecting a 2.55% increase [1] Stock Performance - A total of 102 A-shares had a turnover rate exceeding 20% on this day, with Jianfa Zhixin reaching a turnover rate of over 50% [1] - Notable stocks with high turnover rates include: - Jianfa Zhixin (301584) with a closing price of 37.24 CNY and a turnover rate of 51.30%, increasing by 2.08% [1] - Zhongneng Electric (300062) with a closing price of 10.92 CNY and a turnover rate of 46.19%, increasing by 1.68% [1] - Qingshuiyuan (300437) with a closing price of 18.37 CNY and a turnover rate of 40.46%, increasing by 7.30% [1] - Yao Yigou (300937) with a closing price of 36.21 CNY and a turnover rate of 39.66%, increasing by 3.13% [1] - Haoshanghao (001298) with a closing price of 36.38 CNY and a turnover rate of 39.22%, increasing by 1.39% [1] Additional Notable Stocks - Other stocks with significant turnover rates include: - Dawi Co. (002213) with a turnover rate of 38.59% and a price increase of 4.14% [1] - Fangzheng Electric (002196) with a turnover rate of 38.41% but a decrease of 7.92% [1] - Te Yi Pharmaceutical (002728) with a turnover rate of 37.94% and an increase of 3.13% [1] - Haixia Innovation (300300) with a turnover rate of 37.47% and a notable increase of 10.92% [1] Summary of Turnover Rates - The data indicates a strong trading activity in the market, with several stocks experiencing high turnover rates and notable price movements, suggesting investor interest and potential volatility in these stocks [1][2][3][4]

北京市东城区建国门内大街 26 号新闻大厦 7 层、8 层 电话：010-88004488/66090088 传真：010-66090016 邮编：100005 北京国枫律师事务所 关于上海建发致新医疗科技集团股份有限公司 2025 年第二次临时股东大会的 法律意见书 国枫律股字[2025]A0540 号 致：上海建发致新医疗科技集团股份有限公司（贵公司） 北京国枫律师事务所（以下简称"本所"）接受贵公司的委托，指派律师出席并见 证贵公司 2025 年第二次临时股东大会（以下简称"本次会议"）。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人 民共和国证券法》（以下简称"《证券法》"）、《上市公司股东会规则》（以下简称 "《股东会规则》"）、《律师事务所从事证券法律业务管理办法》（以下简称"《证券法律 业务管理办法》"）、《律师事务所证券法律业务执业规则（试行）》（以下简称"《证券法 律业务执业规则》"）等相关法律、行政法规、规章、规范性文件及《上海建发致新医疗 科技集团股份有限公司章程》（以下简称"《公司章程》"）的规定，就本次会议的召集 与召开程序、召集人资格、出席会议人员资格、 ...

证券代码：301584 证券简称：建发致新 公告编号：2025-013 上海建发致新医疗科技集团股份有限公司 2025年第二次临时股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1.本次股东大会不存在否决议案的情形。 3.会议地点：上海市杨浦区秦皇岛路32号上海建发国际大厦9楼1号会议室 4.召开方式：现场表决与网络投票相结合。 5.现场会议主持人：董事长余峰先生 2.本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 （一）会议召开情况 1.召集人：公司董事会 2.会议时间： （1）现场会议时间：2025年11月12日14:30 （2）网络投票时间：通过深圳证券交易所系统进行网络投票的具体时间为 2025年11月12日9:15-9:25，9:30-11:30，13:00-15:00；通过深圳证券交易所互 联网投票系统投票的具体时间为2025年11月12日9:15至15:00的任意时间。 6. 本次股东大会的召集、召开程序及表决方式符合《中华人民共和国公司法》 等法律、法规、规范性文件和《公司章程》的规定。 ...